Statewide

Vermont Department of Health

Current214 dose entries54 drugs1 documentVTeffective 2025-01-0197% machine-parsed of 214

Vermont Department of Health (VT) carries 54 drugs across 214 dose entries in its current published protocol, effective 2025-01-01.

Drugs and doses54

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1000 mg	IV	not captured	standing	pages 54, 56, 244 · source
Mild to moderate pain	adult	325–1000 mg	PO	not captured	standing	pages 54, 56, 244 · source
Mild to moderate pain	peds	15 mg/kg	PO	not captured	standing	pages 54, 56, 244 · source
Mild to moderate pain	peds	15 mg/kg	IV	not captured	standing	pages 54, 56, 244 · source

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	6 mg	IV/IO	not captured	standing	pages 92, 93, 94, 244 · source
Narrow-complex tachycardia	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 92, 93, 94, 244 · source

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2–4 puff	MDI	not captured	standing	pages 28, 29, 245 · source
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 22, 24, 28, 29, 71, 245 · source
Asthma / bronchospasm	peds	2–4 puff	MDI	not captured	standing	pages 28, 29, 245 · source
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	pages 22, 24, 28, 29, 71, 245 · source
Hyperkalemia	adult	10–20 mg	NEB	not captured	standing	pages 41, 100, 101, 245 · source
Hyperkalemia	peds	Weight-based	NEB	not captured	standing	pages 41, 100, 101, 245 · source

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	pages 93, 245 · source
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	pages 93, 245 · source
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 83, 87, 245 · source
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 83, 87, 245 · source

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	pages 77, 78, 246 · source

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV/IO	not captured	standing	pages 80, 81, 246 · source
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 80, 81, 246 · source
Nerve agent exposure	adult	2 mg	IV/IO	not captured	standing	pages 47, 48, 246 · source
Nerve agent exposure	peds	0.05–0.1 mg/kg	IV/IO	not captured	standing	pages 47, 48, 246 · source

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1000 mg	IV/IO	not captured	standing	pages 80, 247 · source
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	pages 80, 247 · source
Hyperkalemia	adult	500–1000 mg	IV/IO	not captured	standing	pages 41, 247, 272 · source
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	pages 41, 247, 272 · source
Other	adult	1 g	IV/IO	not captured	standing	pages 166, 247 · source
Other	adult	1000 mg	IV/IO	not captured	standing	pages 100, 247 · source
Other	adult	1000 mg	IV/IO	not captured	standing	pages 84, 247 · source

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2000 mg	IV/IO	not captured	standing	pages 80, 247 · source
Beta-blocker / calcium-channel-blocker overdose	peds	100 mg/kg	IV/IO	not captured	standing	pages 80, 247 · source
Hyperkalemia	adult	2000 mg	IV/IO	not captured	standing	pages 41, 247, 272 · source
Hyperkalemia	peds	100 mg/kg	IV/IO	not captured	standing	pages 41, 247, 272 · source
Other	adult	2 g	IV/IO	not captured	standing	pages 166, 247 · source
Other	adult	2000 mg	IV/IO	not captured	standing	pages 100, 101, 247 · source
Other	peds	100 mg/kg	IV/IO	not captured	standing	pages 100, 101, 247 · source

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	10 mg	IV/IO/IM	not captured	standing	pages 21, 247 · source
Adrenal crisis	peds	0.6 mg/kg	IV/IO/IM	not captured	standing	pages 21, 247 · source
Adrenal crisis	peds	0.6 mg/kg	PO	not captured	standing	pages 21, 247 · source
Allergic reaction	adult	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	pages 22, 24, 247 · source
Allergic reaction	peds	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	pages 22, 24, 247 · source
Asthma / bronchospasm	adult	10 mg	IV/IO/IM/PO	not captured	standing	pages 28, 29, 247 · source
Asthma / bronchospasm	peds	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	pages 28, 29, 247 · source
Croup	peds	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	pages 29, 30, 247 · source

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV	not captured	standing	pages 37, 38, 248 · source
Hypoglycemia	adult	25 g	IO	not captured	standing	pages 37, 38, 248 · source
Hypoglycemia	peds	5 mL/kg	IV	not captured	standing	pages 37, 38, 248 · source
Hypoglycemia	peds	5 mL/kg	IO	not captured	standing	pages 37, 38, 248 · source

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IV	not captured	standing	page 248 · source
Nerve agent exposure	adult	10 mg	IM	not captured	standing	pages 58, 248 · source
Nerve agent exposure	peds	0.3 mg/kg	IV	not captured	standing	pages 58, 248 · source
Procedural sedation	adult	5 mg	IV/IO	not captured	standing	pages 80, 248 · source
Procedural sedation	adult	5 mg	IV/IO	not captured	standing	pages 92, 94, 248 · source
Procedural sedation	adult	5 mg	IV	not captured	standing	page 248 · source
Procedural sedation	peds	0.05 mg/kg	IV/IO	not captured	standing	pages 92, 94, 248 · source
Seizure	adult	5–10 mg	IV	not captured	standing	pages 62, 63, 248 · source
Seizure	peds	0.1 mg/kg	IV	not captured	standing	pages 62, 63, 248 · source

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.25 mg/kg	IV	not captured	standing	pages 93, 249 · source

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Dystonic reaction	adult	25–50 mg	IV/IM	not captured	standing	pages 46, 58, 60, 249 · source
Dystonic reaction	peds	0.5 mg/kg	IV/IM	not captured	standing	pages 46, 58, 60, 249 · source
Other	adult	25–50 mg	IV/IO/IM	not captured	standing	pages 22, 24, 249 · source
Other	adult	25–50 mg	PO	not captured	standing	pages 22, 24, 249 · source
Other	adult	25 mg	PO	not captured	standing	pages 46, 249 · source
Other	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 22, 24, 249 · source
Other	peds	1 mg/kg	PO	not captured	standing	pages 22, 24, 249 · source
Other	peds	6.25 mg	PO	not captured	standing	pages 46, 249 · source

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	5–20 mcg/kg	IV/IO	not captured	standing	page 249 · source

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	10 mg	IM	not captured	standing	pages 158, 249 · source
Nausea / vomiting	adult	0.625–1.25 mg	IV/IM	not captured	standing	pages 46, 249 · source
Other	adult	5 mg	IV/IM	not captured	standing	pages 158, 249 · source

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 22, 24 · source
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	pages 22, 24 · source
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	pages 80, 81, 250 · source
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 82, 83, 86, 87, 88, 250 · source
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 82, 83, 86, 87, 88, 250 · source
Croup	peds	3 mg	NEB	not captured	standing	page 29 · source
Other	peds	3 mg	NEB	not captured	standing	page 29 · source

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.3 mg/kg	IV/IO	not captured	standing	pages 176, 251 · source

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	25–100 mcg	IV	not captured	standing	pages 54, 57, 251 · source
Mild to moderate pain	adult	50–100 mcg	IM/IN	not captured	standing	pages 54, 57, 251 · source
Mild to moderate pain	peds	1 mcg/kg	IV	not captured	standing	pages 54, 57, 251 · source
Mild to moderate pain	peds	1 mcg/kg	IM/IN	not captured	standing	pages 54, 57, 251 · source
Post-intubation sedation	adult	50–100 mcg	IV/IO	not captured	standing	pages 135, 137, 251 · source
Post-intubation sedation	peds	1 mcg/kg	IV/IO	not captured	standing	pages 135, 137, 251 · source
Procedural sedation	adult	25–50 mcg	IV	not captured	standing	pages 80, 81, 251 · source
Procedural sedation	adult	50–100 mcg	IV/IO	not captured	standing	pages 141, 251 · source
Procedural sedation	peds	1 mcg/kg	IV	not captured	standing	pages 80, 81, 251 · source
Procedural sedation	peds	1 mcg/kg	IV/IO	not captured	standing	pages 141, 251 · source

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2–5 mg	IV/IO	not captured	standing	pages 80, 81, 252 · source
Beta-blocker / calcium-channel-blocker overdose	adult	2–5 mg	IV/IO	not captured	standing	pages 80, 81, 252 · source
Beta-blocker / calcium-channel-blocker overdose	peds	0.5 mg	IV/IO	not captured	standing	pages 80, 81, 252 · source
Beta-blocker / calcium-channel-blocker overdose	peds	0.5 mg	IV/IO	not captured	standing	pages 80, 81, 252 · source
Hypoglycemia	adult	1 mg	IM	not captured	standing	pages 37, 38, 252 · source
Hypoglycemia	peds	0.5 mg	IM	not captured	standing	pages 37, 38, 252 · source

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg	IM	not captured	standing	pages 158, 252 · source
Other	adult	5 mg	IM	not captured	standing	pages 158, 252 · source

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	100 mg	IV/IO/IM	not captured	standing	page 21 · source
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 21 · source
Hypotension / shock	adult	100 mg	IV/IO/IM	not captured	standing	pages 68, 70 · source

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	pages 71, 253 · source
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	pages 71, 253 · source

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	600 mg	PO	not captured	standing	pages 54, 253 · source

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	pages 22, 24, 28, 29, 245, 253 · source
Asthma / bronchospasm	peds	0.5 mg	NEB	not captured	standing	pages 22, 24, 28, 29, 245, 253 · source

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	4 mg/kg	IM	not captured	standing	pages 158, 159, 254 · source
Agitation	peds	4 mg/kg	IM	not captured	standing	pages 158, 159, 254 · source
Head injury / TBI	adult	4 mg/kg	IM	not captured	standing	pages 114, 254 · source
Head injury / TBI	peds	4 mg/kg	IM	not captured	standing	pages 114, 254 · source
Mild to moderate pain	adult	0.25 mg/kg	IV/IO	not captured	standing	pages 55, 57, 254 · source
Mild to moderate pain	adult	0.5 mg/kg	IM/IN	not captured	standing	pages 55, 57, 254 · source
Mild to moderate pain	peds	0.25 mg/kg	IV/IO	not captured	standing	pages 55, 57, 254 · source
Mild to moderate pain	peds	0.5 mg/kg	IM/IN	not captured	standing	pages 55, 57, 254 · source
RSI induction	adult	2 mg/kg	IV/IO	not captured	standing	pages 176, 254 · source
RSI induction	peds	2 mg/kg	IV/IO	not captured	standing	pages 176, 254 · source

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV	not captured	standing	pages 54, 255 · source
Mild to moderate pain	adult	30 mg	IM	not captured	standing	pages 54, 255 · source

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–1.5 mg/kg	IV	not captured	standing	pages 93, 256 · source
VF / pulseless VT	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 83, 87, 256 · source
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	pages 83, 87, 256 · source

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Post-intubation sedation	adult	1–2 mg	IV/IO	not captured	standing	pages 137, 257, 258 · source
Post-intubation sedation	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 137, 257, 258 · source
Procedural sedation	adult	0.5–1 mg	IV/IO	not captured	standing	pages 127, 257 · source
Procedural sedation	adult	1–2 mg	IM	not captured	standing	pages 127, 257 · source
Procedural sedation	adult	1 mg	IV/IO	not captured	standing	pages 80, 257 · source
Procedural sedation	adult	1 mg	IV/IO	not captured	standing	pages 92, 258 · source
Procedural sedation	adult	2 mg	IM	not captured	standing	pages 80, 257 · source
Procedural sedation	adult	2 mg	IM	not captured	standing	pages 92, 258 · source
Seizure	adult	1–2 mg	IV	not captured	standing	pages 62, 63, 258 · source
Seizure	peds	0.1 mg/kg	IV	not captured	standing	pages 62, 63, 258 · source

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV/IO	not captured	standing	pages 28, 29 · source
Other	adult	2 g	IV/IO	not captured	standing	pages 93, 94, 258 · source
Other	adult	4 g	IV/IO	not captured	standing	pages 53, 62, 258 · source
Other	peds	25–50 mg/kg	IV/IO	not captured	standing	pages 93, 94, 258 · source
Other	peds	40 mg/kg	IV/IO	not captured	standing	pages 28, 29 · source
VF / pulseless VT	adult	1–2 g	IV/IO	not captured	standing	pages 83, 87 · source
VF / pulseless VT	peds	25–50 mg/kg	IV/IO	not captured	standing	pages 83, 87 · source

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	125 mg	IV/IO/IM	not captured	standing	pages 21, 245, 258 · source
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 21, 245, 258 · source
Allergic reaction	adult	1 mg/kg	IV	not captured	standing	pages 22, 24, 258 · source
Allergic reaction	peds	1 mg/kg	IV	not captured	standing	pages 22, 24, 258 · source
Asthma / bronchospasm	adult	125 mg	IV/IO/IM	not captured	standing	pages 28, 29, 258 · source
Asthma / bronchospasm	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 28, 29, 258 · source

Metoclopramide

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	5–10 mg	IV/IM	not captured	standing	pages 46, 258 · source

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg	IV	not captured	standing	pages 93, 259 · source

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	1.25 mg	IV	not captured	standing	page 259 · source
Agitation	adult	2.5 mg	IN	not captured	standing	page 259 · source
Agitation	adult	2.5 mg	IV	not captured	standing	pages 158, 159, 260 · source
Agitation	adult	5 mg	IM	not captured	standing	page 259 · source
Agitation	adult	5 mg	IM/IN	not captured	standing	pages 158, 159, 260 · source
Agitation	peds	0.1 mg/kg	IV	not captured	standing	pages 158, 159, 260 · source
Agitation	peds	0.2 mg/kg	IM/IN	not captured	standing	pages 158, 159, 260 · source
Post-intubation sedation	adult	2.5–5 mg	IV/IO	not captured	standing	pages 137, 259, 260 · source
Post-intubation sedation	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 137, 259, 260 · source
Procedural sedation	adult	2.5 mg	IV/IO/IN	not captured	standing	pages 80, 259 · source
Procedural sedation	adult	2.5 mg	IV/IO/IN	not captured	standing	pages 92, 94, 260 · source
Procedural sedation	adult	5 mg	IM	not captured	standing	pages 80, 259 · source
Procedural sedation	adult	5 mg	IM	not captured	standing	pages 92, 260 · source
Procedural sedation	peds	0.05 mg/kg	IV/IO/IN	not captured	standing	pages 92, 94, 260 · source
RSI induction	adult	0.2 mg/kg	IV/IO	not captured	standing	pages 176, 260 · source
RSI induction	peds	0.2 mg/kg	IV/IO	not captured	standing	pages 176, 260 · source
Seizure	adult	10 mg	IM	not captured	standing	pages 62, 63, 260 · source
Seizure	adult	10 mg	IN	not captured	standing	pages 62, 63, 260 · source
Seizure	adult	5 mg	IV	not captured	standing	pages 62, 63, 260 · source
Seizure	peds	0.1 mg/kg	IV	not captured	standing	pages 62, 63, 260 · source
Seizure	peds	0.2 mg/kg	IM	not captured	standing	pages 62, 63, 260 · source
Seizure	peds	0.2 mg/kg	IN	not captured	standing	pages 62, 63, 260 · source

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2–4 mg	IV	not captured	standing	pages 80, 81, 261 · source
Other	peds	0.1 mg/kg	IV	not captured	standing	pages 80, 81, 261 · source
Mild to moderate pain	adult	2–5 mg	IV/IM	not captured	standing	pages 54, 55, 57, 261 · source
Mild to moderate pain	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 54, 55, 57, 261 · source

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.4–2 mg	IV/IO/IM/IN/SQ	not captured	standing	pages 26, 27, 58, 60 · source
Other	adult	0.4–2 mg	IV/IO/IM/SQ	not captured	standing	pages 55, 57, 261 · source
Other	peds	0.1 mg/kg	IV/IO/IM/IN/SQ	not captured	standing	pages 26, 27, 58, 60 · source
Other	peds	0.1 mg/kg	IV/IO/IM/SQ	not captured	standing	pages 55, 57, 261 · source

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	1 autoinjector	IM	not captured	standing	pages 47, 48, 246 · source
Nerve agent exposure	peds	0.25–1 mg	IM	not captured	standing	pages 47, 48, 246 · source

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 77, 262 · source
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	pages 89, 262 · source

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	1–30 mcg	IV/IO	not captured	standing	pages 68, 70, 263 · source
Hypotension / shock	peds	0.1–2 mcg/kg	IV/IO	not captured	standing	pages 68, 70, 263 · source
Sepsis	adult	1–30 mcg	IV/IO	not captured	standing	pages 65, 66, 263 · source
Sepsis	peds	0.1–1 mcg/kg	IV/IO	not captured	standing	pages 65, 66, 263 · source

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IM/PO/ODT	not captured	standing	pages 46, 263 · source
Nausea / vomiting	peds	0.1 mg/kg	IV/IM/PO/ODT	not captured	standing	pages 46, 263 · source

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15–30 g	PO	not captured	standing	pages 37, 38, 252 · source
Hypoglycemia	peds	15 g	PO	not captured	standing	pages 37, 38, 252 · source

Oxymetazoline

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 spray	IN	not captured	standing	page 39 · source
Other	peds	2 spray	IN	not captured	standing	page 39 · source

Oxytocin

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	10 unit	IM	not captured	standing	pages 51, 53, 264 · source

Phenylephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 spray	IN	not captured	standing	page 39 · source
Other	peds	2 spray	IN	not captured	standing	page 39 · source

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	1–2 g	IV	not captured	standing	pages 47, 48, 265 · source
Nerve agent exposure	peds	25–50 mg/kg	IV	not captured	standing	pages 47, 48, 265 · source

Procainamide

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	10 mg/kg	IV	not captured	standing	pages 93, 265 · source

Prochlorperazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	5–10 mg	IV/IM	not captured	standing	pages 46, 258, 265 · source

Proparacaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 drop	not captured	not captured	standing	pages 103, 265 · source
Other	peds	2 drop	not captured	not captured	standing	pages 103, 265 · source

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1 mg/kg	IV/IO	not captured	standing	page 176 · source

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	adult	1 mEq/kg	IV/IO	not captured	standing	pages 101, 266 · source
Crush injury	peds	1 mEq/kg	IV/IO	not captured	standing	pages 101, 266 · source
Hyperkalemia	adult	1 mEq/kg	IV/IO	not captured	standing	pages 41, 266 · source
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 41, 266 · source
Other	adult	1–2 mEq/kg	IV/IO	not captured	standing	pages 84, 266 · source
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 84, 266 · source
Tricyclic overdose	adult	1–2 mEq/kg	IV/IO	not captured	standing	pages 58, 60, 266 · source
Tricyclic overdose	peds	1–2 mEq/kg	IV/IO	not captured	standing	pages 58, 60, 266 · source

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1.5 mg/kg	IV/IO	not captured	standing	pages 176, 266 · source
RSI induction	peds	1.5 mg/kg	IV/IO	not captured	standing	pages 176, 266 · source

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 drop	not captured	not captured	standing	pages 103, 266 · source
Other	peds	2 drop	not captured	not captured	standing	pages 103, 266 · source

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	1 g	IV/IO	not captured	standing	pages 53, 267 · source
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	pages 118, 267 · source

Vasopressin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	40 unit	IV/IO	not captured	standing	page 267 · source
Hypotension / shock	adult	0.02–0.1 unit	IV	not captured	standing	page 267 · source

Vecuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 177, 267 · source

Cite this

Vermont Department of Health, United States EMS Protocol Census. 214 dose entries, effective 2025-01-01.

https://protoquiz.com/census/agencies/vermont-department-of-health/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.